Women's Hormone Replacement Therapy: Complete Guide 2025

Hormone replacement therapy (HRT) — also called menopausal hormone therapy (MHT) — is the most effective treatment for menopause symptoms and carries significant benefits for long-term health when used appropriately. Yet a 2002 study scared a generation of women and their doctors away from it, and many women still suffer needlessly through menopause when relief is available. In 2026, the evidence supporting HRT for appropriate candidates is stronger than ever. This guide cuts through the confusion.

What Is Hormone Replacement Therapy?

HRT replaces the hormones — primarily estrogen, and often progesterone — that the ovaries stop producing during menopause. The goal is to restore circulating hormone levels to a range that alleviates symptoms and protects long-term health, without the risks associated with supraphysiological (above-normal) levels.

Modern HRT is categorized by:

• Hormone type: Estrogen alone, or combined estrogen + progestogen
• Formulation: Bioidentical vs. synthetic hormones
• Route of delivery: Transdermal (patches, gels, sprays), oral, vaginal, or injectable
• Dosing regimen: Cyclic (mimicking a menstrual cycle) vs. continuous combined

Types of HRT

Estrogen-Only HRT

Estrogen alone is prescribed for women who have had a hysterectomy (uterus removed). Since there is no endometrium to protect, progesterone is not needed. Estrogen-only therapy has a favorable risk-benefit profile and provides the full benefits of estrogen replacement without the complexity of combination therapy.

Combined Estrogen + Progestogen HRT

Women who still have a uterus must use combined HRT. Estrogen alone causes the endometrial lining to thicken, which over time increases the risk of endometrial cancer. Adding a progestogen protects the endometrium. Combined HRT can be:

• Cyclic/sequential: Progestogen is taken for 10–14 days each month; results in a monthly withdrawal bleed (often chosen for perimenopausal women)
• Continuous combined: Both hormones are taken daily without a break; typically used by postmenopausal women and aims to eliminate breakthrough bleeding over time

Bioidentical Hormones

Bioidentical hormones are chemically identical to those naturally produced by the body. Many FDA-approved HRT products — including estradiol and micronized progesterone (Prometrium) — are bioidentical. Compounded bioidentical hormones (from compounding pharmacies) are also available but are not FDA-regulated for purity, potency, or sterility, which is a consideration worth discussing with your provider.

Routes of Delivery

Transdermal Estrogen (Patches, Gels, Sprays)

Transdermal delivery is the preferred route for estrogen replacement in most modern protocols. Unlike oral estrogen, transdermal estrogen bypasses first-pass liver metabolism, meaning it:

• Does not increase clotting factors (oral estrogen raises clotting factor production in the liver, increasing DVT/PE risk; transdermal does not)
• Provides more stable hormone levels (oral estrogen creates peaks and troughs)
• Has a lower impact on triglycerides and C-reactive protein

Patches (changed 1–2x weekly), gels (applied daily to arms or thighs), and sprays (applied to inner wrist) all deliver estradiol transdermally.

Oral Estrogen

Oral estrogens (including conjugated equine estrogens like Premarin, and oral estradiol) are effective but carry slightly higher clotting and stroke risk than transdermal formulations. They remain appropriate for many women, particularly those without cardiovascular risk factors or personal/family history of clotting disorders.

Vaginal Estrogen

Low-dose vaginal estrogen (creams, rings, suppositories) delivers estrogen locally to the vaginal and urethral tissues. It is highly effective for genitourinary syndrome of menopause (GSM) — vaginal dryness, urinary urgency, recurrent UTIs — and has minimal systemic absorption. Vaginal estrogen can be used by women who are not candidates for systemic HRT, including breast cancer survivors in many cases.

Progesterone/Progestogen Options

Micronized progesterone (Prometrium) is bioidentical and has a more favorable safety profile than synthetic progestins. It is associated with better sleep (it has mild sedative properties via GABA receptors), lower breast cancer risk compared to synthetic progestins, and fewer androgenic side effects (bloating, mood changes). The Mirena IUD delivers levonorgestrel locally to the uterus and is an alternative to systemic progestogen for endometrial protection.

Benefits of HRT

Symptom Relief

HRT is the gold-standard treatment for menopausal symptoms:

• Hot flashes and night sweats: Reduced by 75–90% — more effective than any non-hormonal alternative
• Sleep disruption: Night sweat resolution dramatically improves sleep architecture
• Vaginal dryness and discomfort: Restores mucosal tissue, improving comfort and sexual function
• Mood and cognitive symptoms: Reduces depression, anxiety, and brain fog associated with the menopausal transition
• Joint pain: Estrogen has anti-inflammatory effects and many women experience significant joint pain reduction
• Low libido: Improved through symptom relief (pain-free sex, better sleep, better mood) and, if testosterone is added, directly enhanced desire

Bone Health

Estrogen is essential for bone mineral density maintenance. Women lose up to 20% of bone mass in the 5–7 years following menopause — faster than any other period of life. HRT reduces this bone loss, decreasing fracture risk. In the WHI, women on HRT had significantly lower rates of hip and vertebral fractures.

Cardiovascular Health

The "timing hypothesis" is now well-established: estrogen started within 10 years of menopause (or within age 60, the "window of opportunity") is cardioprotective — it reduces LDL cholesterol, improves arterial function, and may reduce atherosclerosis progression. The WHI's cardiovascular findings were confounded by starting HRT in older women (average age 63) who likely already had subclinical cardiovascular disease. Modern data from observational studies and the KEEPS and ELITE trials support cardiovascular benefit when HRT is initiated early.

Diabetes Risk Reduction

HRT improves insulin sensitivity and reduces the risk of type 2 diabetes development — a significant benefit given that menopausal women have substantially elevated metabolic risk.

Cognitive Function

Emerging evidence suggests estrogen may be neuroprotective — reducing the risk of Alzheimer's disease when started early in the menopausal transition. Studies show that vasomotor symptoms (hot flashes) are associated with increased amyloid deposition in the brain, and HRT that eliminates these symptoms may provide cognitive protection. This area of research is active and evolving.

Quality of Life

When the full benefit picture is considered — elimination of hot flashes, restored sleep, improved mood, pain-free sex, maintained body composition — HRT typically produces dramatic improvements in overall quality of life for symptomatic menopausal women.

The Real Risks of HRT

HRT does carry real risks, but they are smaller, more nuanced, and more modifiable than the 2002 WHI study suggested. Understanding the actual numbers helps put them in perspective.

Breast Cancer

The relationship between HRT and breast cancer is the most discussed risk. Key nuances:

• Estrogen-only HRT does not increase breast cancer risk and may actually reduce it (as seen in the WHI estrogen-alone arm)
• Combined HRT with synthetic progestins is associated with a small increased risk — approximately 1 additional case per 1,000 women per year of use (comparable to drinking one glass of wine per night)
• Combined HRT with micronized progesterone (bioidentical) appears to carry lower breast cancer risk than synthetic progestins, based on observational data
• Risk generally returns to baseline within 2–5 years of discontinuing HRT

Women with a personal history of hormone receptor-positive breast cancer should not use systemic HRT without oncology consultation; vaginal estrogen is often permitted.

Blood Clots (VTE) and Stroke

• Oral estrogen increases risk of venous thromboembolism (DVT/PE) by approximately 2–3 fold — though absolute risk remains low
• Transdermal estrogen does not significantly increase clotting risk and is the preferred choice for women with elevated VTE risk (obesity, personal or family history of clotting disorders)
• Stroke risk may be slightly elevated with oral estrogen but not transdermal

Endometrial Cancer

Estrogen alone increases endometrial cancer risk in women with a uterus — this is why combined HRT (with progestogen) is required for uterus-intact women. When progestogen is included, endometrial cancer risk is not elevated and may actually be reduced.

Who Is a Good Candidate for HRT?

HRT is generally appropriate for women who:

• Have bothersome menopausal symptoms (hot flashes, night sweats, sleep disruption, vaginal atrophy)
• Are within 10 years of menopause or under age 60
• Have no personal history of hormone-sensitive breast cancer
• Have no history of blood clots, stroke, or cardiovascular disease (or can use transdermal routes)
• Have elevated osteoporosis or bone fracture risk
• Have experienced early menopause (before age 45) — HRT is strongly recommended in this group to protect bone, heart, and brain health

Premature and Early Menopause

Women who enter menopause before age 45 (especially before 40, called premature ovarian insufficiency) have substantially elevated risks of osteoporosis, cardiovascular disease, and dementia compared to women in natural menopause. HRT is strongly recommended for these women until at least age 51 (the natural average menopause age), as the goal is to replace hormones that would naturally still be present — not to add extra.

Testosterone for Women

Testosterone is the most abundant sex hormone in women (yes, women have testosterone — just at lower levels than men), and levels decline through menopause. Low testosterone in women contributes to low libido, fatigue, reduced muscle mass, and reduced cognitive sharpness. Testosterone replacement for women is increasingly used in HRT protocols — typically applied as a low-dose cream or gel to the inner thigh — and has strong evidence for improving sexual desire and satisfaction. It is currently off-label in the US but is approved in some countries specifically for women's low libido.

How Long Should HRT Be Used?

There is no universal maximum duration for HRT. The old guideline of "minimum dose for minimum time" has been updated by most major menopause societies (including the Menopause Society and the British Menopause Society) to reflect that ongoing HRT use is appropriate when benefits continue to outweigh risks on an individualized basis. Many women continue HRT well into their 60s and beyond, particularly for quality of life, bone protection, and cardiovascular benefits.

Accessing HRT via Telehealth

Telehealth has made HRT significantly more accessible. A comprehensive HRT consultation typically includes:

• Medical history and symptom review
• Bloodwork (hormone levels, cholesterol, glucose, liver function)
• Discussion of formulation options and delivery routes
• Prescription and pharmacy coordination
• Follow-up to optimize dosing

Many women find telehealth more convenient than in-person visits — particularly for ongoing monitoring — and equally effective for managing HRT. Prescriptions for estradiol patches, gels, and micronized progesterone can be sent to any pharmacy.